Everyone wants to be a market leader and innovator, but no one wants to take a risk that could cost them their job. While there is a tremendous interest in strategies that leverage Web 2.0, we have yet to see the kind of traction one might expect given the surrounding media frenzy and accompanying client demand. Most of it is very safe, and does not fully take advantage of what Web 2.0 is all about-collaboration, community, and consumer-generated content.
Everyone wants to be a market leader and innovator, but no one wants to take a risk that could cost them their job. While there is a tremendous interest in strategies that leverage Web 2.0, we have yet to see the kind of traction one might expect given the surrounding media frenzy and accompanying client demand. Most of it is very safe, and does not fully take advantage of what Web 2.0 is all about—collaboration, community, and consumer-generated content.
If a client is interested in exploring a video syndication strategy on a video-sharing Web site like YouTube, the agency needs to be able to properly present the risks and benefits of this tactic. It also needs to be able to effectively articulate for the various company stakeholders (medical, legal, regulatory, IT, brand, PR, privacy, compliance, etc.) the legal and logistical concerns that might arise from embarking on this type of initiative.
What if an idea centers on re-purposing an already existing TV spot? What does this mean then to the text size and context of the fair-balance language that goes with this spot? Since videos can and should be tagged with keywords in order to be found via the site's search engine, what types of keywords are appropriate; how should these be handled from a regulatory perspective? And if "related-videos" might appear alongside the posted video, what is the risk to the company if those accompanying videos present off-label or inappropriate content? Should the ability for people to post comments be open and unmoderated, or should this functionality be "turned off," and what are the options and implications? What resources will be necessary to manage this?
Ignite Health is a full-service healthcare marketing agency
Telephone: 949-861-3200
E-mail: Fabio@ignitehealth.com
Web site: ignitehealth.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.